Mahesh Desai MD, FACP, FAPCR (@mah_ek) 's Twitter Profile
Mahesh Desai MD, FACP, FAPCR

@mah_ek

Board Certified Internal Medicine Physician

ID: 1069765340131966978

calendar_today04-12-2018 01:28:27

3,3K Tweet

76 Followers

449 Following

Shreya (@shreyamatsharma) 's Twitter Profile Photo

Washington Sundar and Ravindra Jadeja have come out of their own shadows of bowling allrounders in this series. They are as good a bat as any. They have progressed their batting reputation immensely. Unfortunately NKR has regressed. Hunt for seam allrounder continues.

BCCI (@bcci) 's Twitter Profile Photo

𝗕𝗲𝗹𝗶𝗲𝗳. 𝗔𝗻𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻. 𝗝𝘂𝗯𝗶𝗹𝗮𝘁𝗶𝗼𝗻! Raw Emotions straight after #TeamIndia's special win at the Kennington Oval 🔝 #ENGvIND

Mahesh Desai MD, FACP, FAPCR (@mah_ek) 's Twitter Profile Photo

What about India has injured Rishabh Pant and Jasprit Bumrah bhai's workload and plus bad luck with siraj in lords and dropped catch by Yashasvi Jaiswal and not to forget that we lost all 5 tosses which is rare and unlucky itself.

Wasim Jaffer (@wasimjaffer14) 's Twitter Profile Photo

Thanks from my content team, Michael. I asked if they could help you too. They read your predictions and said, “Ask him to focus on being content, not producing it.” Don’t listen to them though. I’d hate to lose my permanent social media wicket 😜

Wasim Jaffer (@wasimjaffer14) 's Twitter Profile Photo

Reports of Donald Trump negotiating a ceasefire between me and Michael Vaughan are BASELESS and UNTRUE. The social media war will continue. Thank you for your attention to this matter. #ENGvIND

Sportskeeda (@sportskeeda) 's Twitter Profile Photo

Here is our all-time India XI in Tests played in England. 🇮🇳🏆 Do you agree with the side? 👀 #Cricket #India #Test #England

Here is our all-time India XI in Tests played in England. 🇮🇳🏆

Do you agree with the side? 👀

#Cricket #India #Test #England
THE SKIN DOCTOR (@theskindoctor13) 's Twitter Profile Photo

Trump is threatening a 250% tariff on Indian pharmas. While it would hurt Indian companies initially, they can recover by diversifying exports, as affordable, high-quality generics are in global demand. The real damage would be to US citizens. India supplies 40% of US generics,